Introduction
It has long been recognized that deep vein thrombosis (DVT) may be followed by symptoms of leg swelling, secondary varicose veins, inflammation induration venous claudication and leg Ulceration known v~riously as post-thrombotic or postphlebitic syndrome. An association between acute DVT and the development of leg ulcers was first noted by Leriche! in 1927. Howe.ver, it was Homans, in 1938, who fully descnbed a syndrome of 'post-phlebitic induration and ulceration'< The natural history of untreated DVT was defined by Bauer (1942) . In a classical study of 99 patients followed for. 15 years after phlebographically proven extensive DVT, Bauer described the clinical course and outcome and advocated heparin as a means of reducing complications.P-s
Epidemiology
Definitive and authoritative data on the true prevalence of post-thrombotic syndrome in any population do not exist. The prevalence of varicose veins and of their complications in the skin and subcutaneous tissues are well documented.e-!" The difficulty lies in quantifying the role of DVT within this population, princ!pally~ecause of the problems in establishing the diagnosis of DVT accurately, especially when attempts are made to establish the diagnosis in retrospect. An approximate indication of the prevalence of post-thrombotic syndrome can be arrived at from studies of patients with leg ulcers. The prevalence of chronic leg ulceration was estimated in early studies in various countries to be about 1% of the adult population. I I-IS More recently, four well-designed studies of prevalence of leg ulceration have been carried out.5-8 These were similar in design and produced similar results, revealing a prevalence of active venous ulceration in the range 0.62-0.9 per 1000 total population. These were all surveys in which patients were located through health service workers and institutions. Thus only patients who were receiving active treatment were included. The figures given in these studies are therefore likely to underestimate the true prevalence, as some people with leg ulceration and with milder forms of post-thrombotic syndrome do not seek treatment. However, these figures are economically relevant as they include all patients using health service resources. Only active ulceration was documented in these studies and since only 20-25% of leg ulcers are active at anyone time it can be estimated that the true prevalence of chronic leg ulceration is probably about 5: 1000. 11 When these figures are extrapolated to the UK, it is estimated that about 300 000 people are affected at a cost to the National Health Service of up to £600 million per annurn.f
The proportion of patients with chronic leg ulcers who have a history of deep venous thrombosis varies widely between different studies. Anning reported that in a study of 1026 patients with leg ulcers, 74% had a history of DVT. 16 More recent studies have reported much lower figures; 8% by Cornwall et a/. 5 6 reported that in a study of 138 patients with leg ulcers, 25% of patients had suffered a major limb injury, 45% had undergone a general anaesthetic and overall only 4% of the patients had no predisposing factors for an episode of deep venous thrombosis. In phlebographic studies, objective evidence of post-thrombotic damage has been found in 40% of ulcerated legs. I8 Thus, although the true percentage of patients with venous ulceration whose condition is the result of deep venous thrombosis is not known, it is likely to be in the region of 30-50%.
For each patient with a chronic leg ulcer as a result of DVT there are many more with less severe post-thrombotic symptoms. The percentage of patients with post-thrombotic syndrome who have leg ulceration varies from 5% to 80% in different studies. 4,l9-21 This wide divergence derives from major differences between studies. In some, all the patients had severe iliofemoral thromboses while in others patients with subclinical thromboses were included. Patients have been studied at variable times after the DVT and the diagnostic criteria for post-thrombotic syndrome have varied considerably, In a recent study of patients referred with established post-thrombotic syndrome to a vascular surgical clinic it was found that 25% had open ulceration.P A reasonable estimate is that patients with leg ulcers form 20-50% of all patients with troublesome postthrombotic symptoms,
It can be estimated that as a result of deep venous thrombosis about 100 000-150 000 people in the UK have chronic leg ulceration and a further 200 000-800 000 have less severe symptoms.
Many of these patients are relatively young and their symptoms do not diminish with time. In most studies of post-thrombotic syndrome the mean age of patients is between 45 and 55 years. 19,20,23--25 In the Lothian and Forth Valley Leg Ulcer Study 50% of the men and 25% of the women were below retirement age, 39% had onset of ulceration before the age of 50 and the average length of ulcer history was 15 years with a range of 1-78 years. 17, 26 The cost of treating a leg ulcer in the community for one year is estimated to be between £2,000 and £5,000. 8,27 Some patients require a period of inpatient care which is usually lengthy and therefore costly. There are also indirect costs from loss of earnings due to time absent from work and early retirement. 28 Reduced activity at home may require the employment of a home help. In addition to the financial costs there is a significant effect on patients' quality of life. Patients may suffer pain or discomfort, they have reduced activity and may experience social isolation. Thus the eventual cost stemming from a single episode of deep venous thrombosis can be enormous.
Clinical course and outcome
Despite a great deal of research effort and an increasing number of published studies, the longterm prognosis and the evolution of symptoms with time in patients after acute DVT is still unclear. Early studies portrayed the clinical course as being one of progressive deterioration with poor eventual outcome. In a classical study, Bauer (1942) rigorously followed patients for 15 years after phlebographically proven DVT.4 The incidence of ulceration was proportional to the duration of follow-up, with 20% being affected after five years, 50% after ten years and 80% after 15 years. Hojensgard (1952) stated that 'after ... the first year, the post-thrombotic state subsequently undergoes rather marked exacerbation, particularly during the next five years' and there was a 'constant, progressive exacerbation of the condition',29 However, these studies were carried out in the preheparin era and there is reason to believe that the course of the postthrombotic syndrome can be ameliorated with modern management both of the acute episode and its follow-up.
In most studies patients have been examined at a single point or the follow-up has not been over a significant length of time and there are few published longitudinal studies of patients who have been treated by heparin in the acute phase. Mudge et al. reported that in group of 61 patients who suffered at DVT post-operatively, two developed post-thrombotic syndrome in the first year.>' Over the next six years no patients developed new symptoms and between the seventh and ninth years 4 further patients developed post-thrombotic syndrome. This is a very low incidence of post-thrombotic syndrome and it should be noted that this study included patients who had asymptomatic DVT diagnosed by J125-labelled fibrinogen uptake scans. Patients of this type have been reported as having a favourable outcome. 30-32 Nevertheless this is one of the few studies which has followed a cohort of patients over a prolonged period of time and as such it provides valuable information about the evolution of symptoms following DVT. T~e clinical course suggested is that post-thrombotic syndrome tends to manifest itself within the first year after DVT; thereafter most patients remain stable with only a small number deteriorating at a later stage. This is supported by other authors. Milne and Ruckley reported a longitudinal follow-up study of 83 patients with P~S following phlebographically proven symptomatic DVT.22 During a median follow-up period of four years, 86% of patients remained stable or improved, only 14% deteriorated and 3% developed a new leg ulcer. Thus although some patients do deteriorate with time, this occurs in a much lower proportion than suggested by Bauer. The overall outcome in terms of the numbers of patients developing chronic venous insufficiency (CVI) with oedema, skin changes and leg ulcers, varies widely between studies (see Table 1 ). This eflec.ts varyin.g populations in te~ms of underlymg disease, site of DVT, age, differing lengths of follow-up and variable numbers of patients either excluded from, or lost to, follow-up. The early studies by~a~er (1942) and Hojensgard (1952) report an incidence of severe swelling of 100% and 80% and an incidence of ulceration of 80% and 28% respectivety.s.sv Such high rates of poor outcom~are to be expected as the patients In these studies had severe and extensive initial thromboses .which were not treated by heparin and the patients were followed for many years after DVT. By contrast, studies by Mudge et al. (1988) and Lindhagen et al. (1983) describe the onset of new symptoms of leg swelling in 11% and 9% and new leg ulceration in 2% and 1%.21,33 Such low rates of sequelae are probably due to the fact that these studies ncluded patients in whom DVT was diagnosed In the early postoperative period by 125I-labelled fibrin~gen uptake scanning, a method capable of d~t~ctIn& very small thrombi, and only 28% had clinical signs of DVT. Studies of clinically apparent DVT report higher rates of post-thrombotic swelling and ulceration. Akesson et al. (1990) reported ulceration. in 15% of patients five years after phlebographicalty diagnosed iliofemoral thrombosis. 23. Stu~i~s of a less select group of p(~tIen~s With clinically apparent DVT report swelling In 55-79% and ulceration of 4-5% of patients at five to ten years after thrombosis.rv.zo
In summary, the expected clinical course for a groul? of patients following clinically apparent DVT IS as follows: patients may experience Bauer, 1942 Bauer, H6jensgard, 1952 Strandness, 1983 Akesson, 1990 Mudge, 1988 Halstuck, 1984 Lindner, 1986 Lindhagen, 1983 Browse, 1980 considerable change in symptoms during the first year, some improving and other deteriorating such that at the end of the first year 40% will be asymptomatic or have only very mild swelling, 35% will have marked swelling, 20% will have skin changes and 5% have ulceration. Thereafter most patients remain stable but about l(}-20% suffer deterioration at a later stage.
Pathogenesis of symptoms
Humans are much less efficient than most animal species at clearing thrombus and there is considerable variation between individuals. Complete recanalization has been shown to occur in 30% of patients within 30 days of thrombosis and in 53% at 90 days when treated with heparin.>' Heparin not only limits the extension of thrombus but facilitates the body's lytic processes. A small proportion of patients have complete clearance of thrombus as early as seven days. Others recanalize at a much slower rate with some only achieving complete resolution at up to 270 days and others achieving little or no recanalization at all. Other studies have demonstrated rapid recanalization. In a series of patients examined repeatedly by duplex ultrasonography, 87% of those vein segments which eventually recanalized cleared within six weeks.P> In a small number of patients chronic venous outflow obstruction occurs giving rise to venous claudication -a rare symptom. Valvular reflux in the deep veins develops at varying rates during the first 12 months after thrombosis.P Reflux can be found as early as seven days and is present in about 70% of limbs by the end of 12 months. It is commonly thought that valves are destroyed during recanalization of organized thrombus and it has been shown that reflux is more common in segments which were previously rhrombosed.> However, reflux can develop some time after recanalization.s-In some patients the thrombus clears and the veins can be shown to be competent but on repeated examination some months later it is found that venous reflux has developed.
Venous hypertension, as shown by measurement of resting and ambulatory foot vein pressure, is closely associated with deep venous incompetence.w-'? Patients with severe symptoms following DVT have been shown to have significantly raised ambulatory foot vein pressures.w
Deep venous reflux has consistently been shown to be associated with severe postthrombotic syndrome. Patients who have severe symptoms usually have significant reflux and patients who have no reflux usually only have mild symptoms. 19 • 20 ,38 ,39 However, there is a large group of patients who have severe reflux but whose clinical condition is mild. This heterogeneity amongst patients with deep reflux suggests that some other factor or factors are involved.
Several attempts have been made to link the site of DVT with eventual outcome. Kakkar and Lawrence showed that patients with phlebographically proven thigh vein thromboses had significantly greater venous dysfunction, as determined by foot volumetry, than those with isolated calf vein thromboses.w More patients with proximal thromboses had severe symptoms but this did not reach statistical significance. The presence of reflux in the superficial venous system may contribute to the development of post-thrombotic syndrome. 38 ,39 ,43 It is known that superficial venous reflux, even in the absence of deep venous dysfunction, can lead to leg ulceration. 4 4-4 6 The presence of superficial venous reflux in patients with post-thrombotic syndrome is associated with more severe symptoms.vv'" It has been suggested that much of the benefit of surgical intervention in post-thrombotic syndrome is derived from reduction of reflux in the superficial venous systern.s? Whether superficial venous reflux in these patients is a primary abnormality, bearing in mind that the presence of varicose veins is a well-documented risk factor for DVT, or whether it results from the effects of deep venous obstruction at the time of acute DVT, is often a matter of conjecture in individual patients, Based on the above evidence it seems likely that the mechanism for the development of postthrombotic symptoms is as follows. Thrombus in the deep veins organises and recanalizes slowly and often incompletely. During recanalization valves are destroyed and deep venous reflux develops. Reflux causes venous hypertension which is more marked on exercise. The ambulatory venous hypertension may be aggravated by venous outflow obstruction. Sustained venous hypertension leads to chronic venous insufficiency characterized by skin changes and ulceration, The microcirculatory mechanisms by which this occurs is beyond the scope of this paper and has recently been reviewed.s" This theory is well established but it is challenged on several grounds. The first !s the proposed causal link between thrombosis and the subsequent development of. reflux. As was mentioned above, in some patients reflux has been shown to develop some time after the thrombus has been cleared.P-" In one study the contralateral unaffected limbs were examined and found to have a higher incidence of reflux than the limb affected by DVT. 19 The second challenge is altogether more fundamental and questions the causal link between DVT and the development of post-thrombotic symptoms. A retrospective study by Browse et al. of patients who had suffered a phlebographically proven DVT showed that after ten years symptoms were present in 32% of the contralateral limbs which had been proven to be unaffected by thrombosis." However, these limbs cannot be regarded as true controls since the patients may have had abnormal coagulation and the limbs were subjected to phlebography which itself can cause thrombosis and it is therefore possible that unrecognized thrombosis occurred in the contralateral leg some time after phlebography. Support to this challenge is provided by data from a prospective study by Lindhagen et al.33 In this study 179 patients who had suffered a postoperative DVT diagnosed on 1251-labelled fibrinogen uptake testing were examined after five years. No difference was found between the affected and unaffected limbs. However, once again it must be stated that the contralateral limb cannot be considered a true control for reasons given above, Furthermore DVTs diagnosed by the 1251-labelled fibrinogen uptake test are often minor thromboses and it has been shown that such events are often not followed by venous dysfunction and carry little risk of PTS.30--32 All patients in this s,tudy were receiving anticoagulants during the penod that the DVT developed, which may have led to quicker clearance of thrombus and thus affected the natural history of the disease.
However, these findings are not supported by the results of a similar study, the South Wales Dextran Trial of DVT prophylaxis in surgical patients. 21, 49 In this trial all patients routinely had 1251-labelled fibrinogen scans, As part of the protocol the presence or absence of prior symptoms of venous insufficiency was documented. Most importantly these trials provided control groups who had been proven not to hav~DVT by 1251-labelled fibrinogen uptake testing. At ten-year follow-up it was found that there was a fourfold greater incidence of new post-thrombotic syndrome in patients who had suffered a clinically diagnosed postoperative DVT at index operation compared with those who had no clinical evidence of DVT and an ll-fold increase in those who had suffered a DVT diagnosed by 1251-labelled fibrinogen uptake testing compared with those who had a n.or'!1~1 scan. These differences were statistically significant and suggest an association between DVT and the development of post-thrombotic syndrome.
Prognostic indicators
Which patients go on to develop post-phlebitic sequelae? Clinically and medicolegally it would be very valuable to be able to predict. In practice it is difficult. The majority of published studies are retrospective and are of little assistance. In one of the few prospective studies, Strandness et al. reported that proximal thromboses and thromboses affecting the whole leg, diagnosed by phlebography, were more likely to result in troublesome post-thrombotic symptoms.>' This finding is of limited value as the differences, although significant, were not great. Symptoms occurred in 74% of those with iliofemoral thromboses, 57% of those with femoropopliteal thromboses and 43% of those with below-knee thromboses. Also in this study Doppler ultrasound examination provided a prognostic indication with 77% of those with abnormal findings developing symptoms compared with 42% of those with normal findings.
In a prospective study, Kakkar and Lawrence showed that, compared with patients suffering a distal DVT, those with proximal DVT, as diagnosed by ascending phlebography, had a significantly higher incidence of deep venous dysfunction at follow-up two years post-DVT.40 A greater number of those with proximal thromboses had severe symptoms although this was not statistically significant. The length of follow-up in this study is relatively short and the authors hypothesized that haemodynamic deterioration precedes clinical deterioration and that over a longer period of follow-up more of those with proximal thromboses and with deep venous reflux would suffer deterioration.
A recent publication showed that more patients with proximal DVT suffered from oedema when compared with patients suffering distal DVT but this difference was not significant in the relatively small number of patients involved. 50 In this same paper it was shown that the clinical signs of the acute DVT did not predict for outcome and that levels of plasminogen activator inhibitor did not correlate with outcome.
A history of venous disease prior to the episode of DVT has been shown to be associated with poor long-term outcome.>' This is supported by evidence from a study of patients receiving thrombolytic therapy for DVT in which it was shown that patients with no prior thrombotic disease had a better long-term outcome.S'
Management
The accepted treatment for acute DVT is initial heparin therapy followed by warfarin therapy. Venous thrombectomy is seldom employed. Thrombolysis with agents such as streptokinase has been shown to reduce post-thrombotic complications, but the incidence of bleeding complications is too great to justify therapy on these grounds alone and thrombolysis is reserved for selected cases. 51-53 The role of newer thrombolytic agents such as tissue plasminogen activator in preventing post-thrombotic syndrome remains unclear. 54.55 As with all chronic venous disorders the most important aggravating factors are obesity, limb dependency and locomotor disorders, especially those which impair the calf muscle pump. These should, as far as possible, be corrected. All patients with post-thrombotic symptoms, except those with severe arterial disease, should be prescribed and encouraged to wear good-quality graduated compression stockings. For most patients below-knee stockings are sufficient, the degree of compression being adjusted to the patient's build and the severity of symptoms. Stockings should be professionally fitted and renewed at least six monthly. In addition, patients should be instructed to elevate the limb at rest, to sleep with the foot of the bed elevated and to avoid long periods of standing. For most patients this form of conservative management is all that is required.
A variety of surgical procedures have been advocated for the treatment of venous insufficiency following DVT.47,56-60 These range from saphenous vein and incompetent perforator vein ligation to valve repair either by valve transposition or reconstruction and various forms of bypass, with or without adjuvant arteriovenous fistula. These procedures, with the possible exception of the Palma operation (femorofemoral cross-over), have not gained widespread acceptance and are still in the realms of surgical experiment. Careful patient selection on the basis of vascular laboratory investigation and high-quality phlebography is of paramount importance in achieving good results.
